Clinical trial
The Effect of Z-338 in Subjects With Functional Dyspepsia
NCT00458328 · Zeria Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00458328 |
|---|---|
| Title | The Effect of Z-338 in Subjects With Functional Dyspepsia |
| Official title | The Effect of Z-338 in Subjects With Functional Dyspepsia, Evaluate the Function of Gastro-duodenum by Ultrasound |
| Lead sponsor | Zeria Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Functioanl Dyspepsia |
| Intervention type | Drug |
| Interventions | Z-338 |
| Enrollment | 40 |
| Start date | Apr 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | Apr 10, 2007 |
| Last update posted | Nov 23, 2010 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: